AZN
E505477
AZN is the stock ticker symbol for AstraZeneca, a major global biopharmaceutical company known for developing prescription medicines across several therapeutic areas.
Observed surface forms (1)
| Surface form | Occurrences |
|---|---|
| AstraZeneca plc | 0 |
Statements (41)
| Predicate | Object |
|---|---|
| instanceOf |
biopharmaceutical company
ⓘ
public company ⓘ stock ticker symbol ⓘ |
| associatedWithTherapeuticArea | oncology ⓘ |
| countryOfIncorporation | United Kingdom NERFINISHED ⓘ |
| currency | USD NERFINISHED ⓘ |
| currencyOfPrimaryListing | GBX ⓘ |
| developed | Vaxzevria COVID-19 vaccine NERFINISHED ⓘ |
| develops | prescription medicines ⓘ |
| exchangeCountry |
United Kingdom
NERFINISHED
ⓘ
United States NERFINISHED ⓘ |
| famousForProduct |
Farxiga
NERFINISHED
ⓘ
Imfinzi NERFINISHED ⓘ Lynparza NERFINISHED ⓘ Symbicort NERFINISHED ⓘ Tagrisso NERFINISHED ⓘ |
| focusesOnTherapeuticArea |
cardiovascular
ⓘ
immunology ⓘ metabolism ⓘ oncology ⓘ rare diseases ⓘ renal ⓘ respiratory ⓘ |
| formedByMergerOf |
Astra AB
NERFINISHED
ⓘ
Zeneca Group plc NERFINISHED ⓘ |
| foundedIn | 1999 ⓘ |
| hasADR | AZN NERFINISHED ⓘ |
| hasCEO | Pascal Soriot NERFINISHED ⓘ |
| hasISIN | GB0009895292 ⓘ |
| hasPrimaryListingCountry | United Kingdom NERFINISHED ⓘ |
| headquarteredIn | Cambridge, United Kingdom NERFINISHED ⓘ |
| industry |
biotechnology
ⓘ
pharmaceuticals ⓘ |
| listedOn |
London Stock Exchange
NERFINISHED
ⓘ
NASDAQ ⓘ |
| represents | AstraZeneca plc NERFINISHED ⓘ |
| sector | healthcare ⓘ |
| securityType | equity ⓘ |
| tradesUnderTicker | AZN NERFINISHED ⓘ |
| underlyingCompanyIndustry | biopharmaceuticals ⓘ |
| underlyingCompanyName | AstraZeneca plc NERFINISHED ⓘ |
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.